[1]
Vallejos Paredes, M.F. et al. 2026. Analysis of the cellular viability and migratory capacity of triple-negative breast cancer cells stimulated with doxorubicin used during neoadjuvant chemotherapy. LACCEI. 1, 14 (July 2026). DOI:https://doi.org/10.18687/LACCEI2026.1.1.1479.